Literature DB >> 16613735

Paraoxonase/arylesterase in serum of patients with type II diabetes mellitus.

Dubravka Juretić1, Alena Motejlkova, Branka Kunović, Branka Rekić, Zlata Flegar-Mestrić, Lovorka Vujić, Ranko Mesić, Jana Lukac-Bajalo, Vera Simeon-Rudolf.   

Abstract

The aim of this study was to determine whether the paraoxonase (PON1) status, i.e. PON1 activities and phenotypes (AA, AB and BB), and its relationship with lipid status are different in patients with type II diabetes as compared to healthy population. Diabetic group comprised 175 patients with type II diabetes mellitus (94 men and 81 women) who came to their regular control examination and took the oral glucose tolerance test. Patients with type II diabetes mellitus diagnosis for 12 years on average were on peroral antidiabetics, or insulin or diet, and 3 patients had no therapy prescribed yet. Control group comprised 114 apparently healthy individuals (28 men and 86 women) who were not on any medication. The paraoxonase activity was measured with 2.0 mmol L(-1) paraoxon in the absence and in the presence of 1.0 mol L(-1) NaCl, and with 2.0 mmol L(-1) phenylacetate. Both activities were measured spectrophotometrically at 37 degrees C in 0.1 mol L(-1) Tris-HCl buffer, pH = 8.0, containing 2.0 mmol L(-1) CaCl(2). Sera of diabetic and control subjects were assigned to the paraoxonase phenotypes on the basis of the basal paraoxonase activity distribution. We assigned 45% sera of male and 49% sera of female diabetic patients, and 64% sera of both genders of the control group to the AA low activity phenotype. There were no differences in paraoxonase activities between the gender- and phenotype-matched diabetic and control groups. Enzyme activity against the phenylacetate was higher, and phenotype-dependent, only in diabetic patients. In contrast to AA phenotype individuals, total cholesterol and LDL-cholesterol in the female diabetic group and triglyceride concentration in the male diabetic group assigned to pooled AB and BB phenotypes were higher than in the corresponding controls. It follows from PON1 phenotype distribution that less antiatherogenic paraoxonase B allele is more frequent in type II diabetes mellitus than in the healthy population. Their lipid status is more atherogenic, which could indicate a risk of premature atherosclerosis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16613735

Source DB:  PubMed          Journal:  Acta Pharm        ISSN: 1330-0075            Impact factor:   2.230


  9 in total

1.  Soluble Lectin-Like Oxidized LDL Receptor 1 as a Possible Mediator of Endothelial Dysfunction in Patients With Metabolic Syndrome.

Authors:  S Civelek; M Kutnu; H Uzun; F Erdenen; E Altunoglu; G Andican; A Seven; A O Sahin; G Burcak
Journal:  J Clin Lab Anal       Date:  2014-05-05       Impact factor: 2.352

2.  Evaluation of Relationship Between Arylesterase-Based Activity and Genetic Variants of Paraoxonase1 in T2DM Patients within Golestan Province.

Authors:  Safoura Khajeniazi; Raheleh Shakeri; Abdoljalal Marjani
Journal:  Indian J Clin Biochem       Date:  2019-03-05

3.  Homology modeling of human serum paraoxonase1 and its molecular interaction studies with aspirin and cefazolin.

Authors:  Mohammed Salman; Chandramouli Malleda; Narayanavari A Suneel; Insaf A Qureshi; Elizabeth A Frank; Cletus Jm D'Souza
Journal:  Bioinformation       Date:  2011-09-06

4.  Effect of pre-germinated brown rice intake on diabetic neuropathy in streptozotocin-induced diabetic rats.

Authors:  Seigo Usuki; Yukihiko Ito; Keiko Morikawa; Mitsuo Kise; Toshio Ariga; Michael Rivner; Robert K Yu
Journal:  Nutr Metab (Lond)       Date:  2007-11-23       Impact factor: 4.169

5.  Punicalagin Decreases Serum Glucose Levels and Increases PON1 Activity and HDL Anti-Inflammatory Values in Balb/c Mice Fed a High-Fat Diet.

Authors:  Dana Atrahimovich; Abraham O Samson; Ali Khattib; Jacob Vaya; Soliman Khatib
Journal:  Oxid Med Cell Longev       Date:  2018-07-31       Impact factor: 6.543

6.  Strychnos nux-vomica L. seed preparation promotes functional recovery and attenuates oxidative stress in a mouse model of sciatic nerve crush injury.

Authors:  Aroona Razzaq; Ghulam Hussain; Azhar Rasul; Jiaqi Xu; Qiqi Zhang; Shoaib Ahmad Malik; Haseeb Anwar; Nimra Aziz; Nady Braidy; Jose-Luis Gonzalez de Aguilar; Wei Wei; Jiang Li; Xiaomeng Li
Journal:  BMC Complement Med Ther       Date:  2020-06-11

7.  Effect of dietary tryptophan supplementation on growth performance, immune response and anti-oxidant status of broiler chickens from 7 to 21 days.

Authors:  Muhammad D Mund; Muhammad Riaz; Muhammad A Mirza; Zia-Ur Rahman; Tahir Mahmood; Fawad Ahmad; Ahmad Ammar
Journal:  Vet Med Sci       Date:  2019-11-05

8.  Oxytocin induced oxidative stress in lactating Bubalis bubalis (Nili Ravi).

Authors:  Zafar Iqbal; Zia Ur Rahman; Faqir Muhammad; Tanweer Khaliq; Haseeb Anwar; Mian Muhammad Awais; Saima Sadaf
Journal:  BMC Vet Res       Date:  2013-08-27       Impact factor: 2.741

9.  Frontocingulate Dysfunction Is Associated with Depression and Decreased Serum PON1 in Methamphetamine-Dependent Patients.

Authors:  Nooshin Ghavidel; Fariba Khodagholi; Abolhassan Ahmadiani; Reza Khosrowabadi; Sareh Asadi; Jamal Shams
Journal:  Neuropsychiatr Dis Treat       Date:  2020-02-19       Impact factor: 2.570

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.